Trials / Completed
CompletedNCT00318669
Social Anxiety Disorder Study Of Paroxetine
Clinical Evaluation of BRL29060A (Paroxetine Hydrochloride Hydrate) in Social Phobia/Social Anxiety Disorder (SAD) -A Double-blind, Placebo-controlled Study- <Phase III Study>
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 390 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to evaluate the efficacy and safety in Social Anxiety Disorder (SAD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine hydrochloride hydrate |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2006-11-01
- Completion
- 2006-11-01
- First posted
- 2006-04-27
- Last updated
- 2013-04-15
Locations
16 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00318669. Inclusion in this directory is not an endorsement.